Future Potential to Leverage HempFusion’s
CBD Portfolio at Retailer
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF)
(FWB:8OO) (“HempFusion” or the “Company”), a leading health and
wellness Company offering premium probiotic supplements and
products containing CBD, is pleased to announce that its
wholly-owned subsidiary, Sagely Enterprises, Inc. (“Sagely
Naturals”), has launched four SKUs of Over The Counter (“OTC”)
topical pain relief products exclusively into a Top 10 US publicly
listed Food, Drug & Mass (“FDM”) retailer in over 1,100 stores
to start.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20211020005322/en/
Sagely Naturals (Photo: Business
Wire)
These products represent a planned brand extension for Sagely
Naturals, as the Company continues to extend the brand’s strength
across its strong, female centric consumer base. Leveraging the
expertise and experience of HempFusion’s regulatory team, Sagely
Naturals has been able to formulate, market and sell this full line
of non-CBD, OTC Drug Listed pain products exclusively into this
leading FDM retailer. This represents a milestone in HempFusion’s
strategy to build its brand into a leading, diversified health and
wellness company across North America.
With thousands of locations across the U.S., this FDM retailer
presents a significant potential opportunity for future expansion
and one of the Company’s main retail targets. Additionally, this is
a new retail relationship for the Company, providing a test-run for
future opportunities around hemp-derived CBD products based on
potential regulatory environment changes.
“We believe the topical pain products we’re launching with this
new FDM retailer provide a new entry point for consumers who have
been deeply interested in more natural ingredients,” said Kerrigan
Behrens, co-CEO of Sagely Naturals. “With this collection, we are
seizing an opportunity for disruption. Legacy brands haven’t
innovated beyond their core offerings and packaging designs in
years, leaving the category somewhat stagnant. We’ve not only
addressed these issues but also capitalized on the fact that most
brands do not address the unique needs of women. Over 80% of our
direct-to-consumer shoppers are women, giving us unique insight
into precisely catering to their unique needs and offering
medicine-cabinet options that are crafted specifically for
them.”
“One of the main reasons we acquired Sagely Naturals was due to
the strength of the brand, most notably their core group of female
centric consumers who typically control a significant portion of
household spending,” said Jason Mitchell, N.D., HempFusion’s
Co-Founder and Chief Executive Officer. “This product launch is
part of the Company’s plan to become a leading diversified health
and wellness company across the United States. The addition of this
key FDM retailer is additive to HempFusion’s existing distribution
footprint of over 15,000 stores and helps our family of brands
build a relationship with one of the largest retailers in North
America as we prepare for potential regulatory changes around CBD
that could result from two hemp CBD Bills currently proceeding
through Congress,” continued Dr. Mitchell.
Sagely Naturals invokes excitement and exploration in the pain
relief category by providing products that emphasize a delightful
user experience – products that the consumer can look forward to
using because they look beautiful and smell and feel great. Sagely
Naturals offers natural products that harness the power of cooling
menthol for soothing pain relief as well as other important skin
supporting cosmetic ingredients including Boswellia Serrata,
vibrant peppermint, camphor, and safflower.
ABOUT HEMPFUSION
One of a select few CBD companies who are today fully prepared
to meet or exceed expected FDA guidance, HempFusion Wellness Inc.
is a leading health and wellness company whose family of premium
consumer brands include HempFusion™, Sagely Naturals™,
Apothecanna™, and Probulin Probiotics™, one of the fastest-growing
probiotics companies in the United States according to SPINs
reported data.
Utilizing the power of whole-food hemp nutrition, the HempFusion
family of brands’ product portfolio comprises 112 SKUs including
USDA Organic Certified Tinctures, proprietary FDA Drug Listed
Over-The-Counter (OTC) Topicals, probiotic supplements and skin
care products, a Doctor/Practitioner line, a White Label division
and more. With a strong focus on research and development,
HempFusion Wellness has 43 products under development.
Available from more than 15,000 US retail locations across all
50 states, HempFusion Wellness products are also available in
China, Mexico, Ireland, United Kingdom, United Arab Emirates, South
Korea and Canada and may be purchased online from each brand’s
website, The Probulin Store on Amazon.com, Alibaba’s Tmall.com, the
world’s largest cross-border online marketplace, and a multitude of
additional e-commerce sites.
For more information, visit www.hempfusion.com. Follow
HempFusion on Twitter, Facebook and Instagram.
ABOUT SAGELY NATURALS
Founded in 2015 by Kerrigan Behrens and Kaley Nichol, Sagely
Naturals is the largest woman-founded CBD wellness brand,
consistently maintaining the number one position in CBD topicals
according to IRI data. Since its inception, the brand has been on a
mission to naturally modernize the medicine cabinet with
high-quality, accessible products that help women feel their best
by harnessing the power of botanicals and CBD. Sagely Naturals was
acquired by HempFusion in July 2021 and operates as a wholly-owned
subsidiary of the Company.
Sagely Naturals maintains a strong presence in top drug
retailers nationwide including CVS, Rite Aid, Albertsons, Ulta,
Nordstrom, numerous independent regional grocers and natural food
stores as well as numerous women’s luxury e-commerce sites.
All of Sagely Naturals’ products are made to exceed the
industry’s high standards, formulated with clean and natural
ingredients, Leaping Bunny Certified, and vegan.
Visit Sagely Naturals at www.sagelynaturals.com and follow on
Twitter, Facebook and Instagram.
FORWARD-LOOKING STATEMENTS
This news release contains forward-looking statements and
forward-looking information within the meaning of Canadian
securities legislation (collectively, “forward-looking
statements“) that relate to HempFusion’s current expectations
and views of future events. Any statements that express, or involve
discussions as to, expectations, beliefs, plans, objectives,
assumptions or future events or performance (often, but not always,
through the use of words or phrases such as “will likely result”,
“are expected to”, “expects”, “will continue”, “is anticipated”,
“anticipates”, “believes”, “estimated”, “intends”, “plans”,
“forecast”, “projection”, “strategy”, “objective” and “outlook”)
are not historical facts and may be forward-looking statements and
may involve estimates, assumptions and uncertainties which could
cause actual results or outcomes to differ materially from those
expressed in such forward-looking statements. No assurance can be
given that these expectations will prove to be correct and such
forward-looking statements included in this news release should not
be unduly relied upon. These statements speak only as of the date
of this news release. In particular and without limitation, this
news release contains forward-looking statements relating to the
Company’s brand and retail expansion plans, future opportunities
around hemp-derived CBD products and the Company’s other plans,
focus and objectives.
Forward-looking statements are based on a number of assumptions
and are subject to a number of risks and uncertainties, many of
which are beyond HempFusion’s control, which could cause actual
results and events to differ materially from those that are
disclosed in or implied by such forward-looking statements. Such
risks and uncertainties include, but are not limited to, the impact
and progression of the COVID-19 pandemic and other factors set
forth under “Cautionary Note Regarding Forward-Looking Statements”
and “Risk Factors” in the annual information form of the Company
dated March 31, 2021, and available under the Company’s profile on
SEDAR at www.sedar.com. HempFusion undertakes no obligation to
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, except as
may be required by law. New factors emerge from time to time, and
it is not possible for HempFusion to predict all of them or assess
the impact of each such factor or the extent to which any factor,
or combination of factors, may cause results to differ materially
from those contained in any forward-looking statement. Any
forward-looking statements contained in this news release are
expressly qualified in their entirety by this cautionary
statement.
Neither the TSX nor its Regulation Services Provider (as that
term is defined in the policies of the TSX) accepts responsibility
for the adequacy or accuracy of this release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211020005322/en/
Investor Relations: Eric Balshin +1 437-826-9911
eric@sophiccapital.com
Company Contact: Jason Mitchell, N.D. Chief Executive Officer
and Director ir@hempfusion.com
HempFusion Wellness (TSX:CBD.U)
Graphique Historique de l'Action
De Mar 2025 à Avr 2025
HempFusion Wellness (TSX:CBD.U)
Graphique Historique de l'Action
De Avr 2024 à Avr 2025
